Selective serotonin reuptake inhibitor use during pregnancy and possible neonatal complications

被引：0
作者：
Jillan Cantor Sackett
Ronald A. Weller
Elizabeth B. Weller
机构：
[1] Thomas Jefferson University Hospital,Department of Psychiatry
来源：
Current Psychiatry Reports | 2009年 / 11卷
关键词：
Pregnant Woman; Major Depressive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitor; Maternal Depression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
This paper reviews the risks and benefits of using selective serotonin reuptake inhibitors (SSRIs) in pregnant women. The effects of SSRI use on pregnant women and fetuses are discussed, and the need for SSRI treatment is explained. Persistent pulmonary hypertension of the newborn, teratogenic risks of SSRI treatment during pregnancy, neonatal adaptations, and long-term outcomes for children whose mothers used SSRIs during pregnancy are specifically considered. Due to conflicting results from current studies, there are no clear guidelines for SSRI treatment in pregnancy. Patients and doctors must discuss together the risks and benefits of SSRI use during pregnancy and decide on a course of treatment. Potential risks must be balanced against the effects of untreated maternal depression.
引用
收藏
页码：253 / 257
页数：4
相关论文
共 50 条
[41]   Onset of Transient Sadness Following the Concomitant Use of a Triptan and Selective Serotonin Reuptake Inhibitor/Serotonin Norepinephrine Reuptake Inhibitors Therapy: A Case Report [J].
Meng, Yuki ;
Yuen, Jamie .
JOURNAL OF PHARMACY PRACTICE, 2023, 36 (03) :705-710
[42]   Selective serotonin reuptake inhibitor use associates with apathy among depressed elderly: A case-control study [J].
Wongpakaran N. ;
van Reekum R. ;
Wongpakaran T. ;
Clarke D. .
Annals of General Psychiatry, 6 (1)
[43]   Catechol O-methyltransferase pharmacogenomics and selective serotonin reuptake inhibitor response [J].
Ji, Y. ;
Biernacka, J. ;
Snyder, K. ;
Drews, M. ;
Pelleymounter, L. L. ;
Colby, C. ;
Wang, L. ;
Mrazek, D. A. ;
Weinshilboum, R. M. .
PHARMACOGENOMICS JOURNAL, 2012, 12 (01) :78-85
[44]   Selective serotonin reuptake inhibitor treatment of major depressive disorder in children and adolescents [J].
Jeffrey H. Newcorn .
Current Psychiatry Reports, 2004, 6 (2) :85-87
[45]   Catechol O-methyltransferase pharmacogenomics and selective serotonin reuptake inhibitor response [J].
Y Ji ;
J Biernacka ;
K Snyder ;
M Drews ;
L L Pelleymounter ;
C Colby ;
L Wang ;
D A Mrazek ;
R M Weinshilboum .
The Pharmacogenomics Journal, 2012, 12 :78-85
[46]   Selective serotonin reuptake inhibitor-induced galactorrhea with hyperprolactinemia [J].
Bhattacharjee, Subir ;
Biswas, Ranjan ;
Mandal, Nikhiles .
INDIAN JOURNAL OF PSYCHIATRY, 2021, 63 (06) :613-616
[47]   Vortioxetine: A multimodal antidepressant or another selective serotonin reuptake inhibitor? [J].
Keks, Nicholas A. ;
Hope, Judy ;
Culhane, Christine .
AUSTRALASIAN PSYCHIATRY, 2015, 23 (03) :210-213
[48]   Bioimpedance in monitoring of effects of selective serotonin reuptake inhibitor treatment [J].
Alexeev, Vasiliy Grigorievich ;
Kuznecova, Ludmila Vasilievna .
PSYCHOLOGY RESEARCH AND BEHAVIOR MANAGEMENT, 2011, 4 :81-86
[49]   Use of Selective Serotonin Reuptake Inhibitors in Children and Adolescents [J].
Ian C.K. Wong ;
Frank M.C. Besag ;
Paramala J. Santosh ;
Macey L. Murray .
Drug Safety, 2004, 27 :991-1000
[50]   Alterations in Resting-State Networks Following In Utero Selective Serotonin Reuptake Inhibitor Exposure in the Neonatal Brain [J].
Rotem-Kohavi, Naama ;
Williams, Lynne J. ;
Virji-Babul, Naznin ;
Bjornson, Bruce H. ;
Brain, Ursula ;
Werker, Janet F. ;
Grunau, Ruth E. ;
Miller, Steven P. ;
Oberlander, Tim F. .
BIOLOGICAL PSYCHIATRY-COGNITIVE NEUROSCIENCE AND NEUROIMAGING, 2019, 4 (01) :39-49
12345